<span>superposition.. its literally word for word "secondary layers are placed on top of the first layers which are on the bottom"</span>
Answer:
White-tailed deer fill the niche, or role, in ecosystems of both herbivore and prey. They are affected by, and themselves affect, their ecosystem. In forests, they have been described as a “keystone species” because their feeding activity can directly and indirectly affect many plants and animals.
The mutation that occurred in the mouse is a silent mutation since it does not affect the amino acid sequence in the protein.
<h3>What is a mutation?</h3>
A mutation is a change that occurs in the sequence of nucleotides in the DNA of organisms.
A mutation can either have deleterious effect on the organism or have no effect at all. Mutations that do not have any effect on the organism are known as silent mutations.
Silent mutations do not affect the sequence of amino acids that make up a protein.
Therefore, the mutation that occurred in the mouse is a silent mutation since it does not affect the amino acid sequence in the protein.
Learn more about silent mutation at: brainly.com/question/2834752
#SPJ1
Answer:
Geology
Explanation:
Geology is the study of rocks and the earth and is a different field of science
Answer:
Explanation:
Synovial joints, often referred to as joints, are composed of two or more bones with a gap between the opposite bone surfaces, connected only by the fibrous connective tissue membrane around them. The synovial joint is the main form of bone joint and has great mobility.
<em>The preclinical trial of therapy against Alzheimer’s disease (AD) is an essential and complex step. It functions as a bridge between candidate discovery and clinical development since it constantly provides us with new information on pieces of the complex AD puzzle. Analysis of this information is likely to reveal patterns of pharmacological interactions instead of the single potential drug target. A group of well-trained, knowledgeable medicinal biochemists in Alzheimacy with decades of experience in preclinical research are willing to work with leaders and scientists from academia, pharmaceutical and biotechnology companies around the world to further develop more promising and stringent therapeutics for AD.</em>
<em>https://www.creativebiomart.net/alzheimacy/solutions/preclinical-development/</em>
